Liminal Biosciences Inc

-0.05 (-1.52%)
Debt Financing / Related, Divestitures / Spin-offs, Earnings Announcements

Liminal BioSciences Announces Signature Of A Share Purchase Agreement

Published: 06/23/2021 13:28 GMT
Liminal Biosciences Inc (LMNL) - Liminal Biosciences Announces Signature of a Share Purchase Agreement for Sale of Remaining Plasma-derived Business With Kedrion.
Liminal Biosciences Inc - Share Purchase Agreement Provides for Payment of USD 5 Million Payable Upon Closing of Sale of Shares of Pbp.
Liminal Biosciences - Kedrion Exercised Its Option to Acquire Remainder of Co's Plasma-derived Business Under Terms of Share Purchase Agreement.
Revenue is expected to be $0.18 Million
Adjusted EPS is expected to be -$0.42

Next Quarter Revenue Guidance is expected to be $0.19 Million
Next Quarter EPS Guidance is expected to be -$0.35

More details on our Analysts Page.